Raymond James analyst Aaron Kessler downgrades Frontdoor (NASDAQ:FTDR) from Outperform to Market Perform.
Two Trial Halts In A Row – Gilead Sciences Stops Late Stage COVID-19 Study
Gilead Sciences Inc (NASDAQ: GILD) said it has
Raymond James Downgrades Frontdoor to Market Perform
Raymond James analyst Aaron Kessler downgrades Frontdoor (NASDAQ:FTDR) from Outperform to Market Perform.
Related Posts
‘Massachusetts Recreational Marijuana Sales Have Officially Exceeded $4B, State Regulators Announce’ – Marijuana Moment
https://www.marijuanamoment.net/massachusetts-recreational-marijuana-sales-have-officially-exceeded-4-billion-state-regulators-announce/
Massachusetts adult-use marijuana sales have officially exceeded $4
Montauk Renewables Q2 EPS $0.13, Inline, Sales $67.88M Beat $50.70M Estimate
Montauk Renewables (NASDAQ:MNTK) reported quarterly earnings of $0.13 per share which met the analyst consensus estimate. This is a 533.33 percent increase over losses of $(0.03) per share from the same period last year.
US Foods Raises $1B Through Debt Offering
US Foods Holding Corp (NYSE: USFD) has commenced a private offering of $1.0 billion aggregate principal amount of notes, consisting of senior unsecured notes due 2028 and senior unsecured notes due 2032 by its